We'll have to see how things trade today, but so far, the market seems to like the diabetes story and not the skin lightener. I personally like the skin lightener story better, proprietory technology, quick to market, no regulatory hurdles, fully funded to commercialization.


The diabetes market is so crowded, but of course much larger and therefore a bigger reward and a corresponding risk. At the end of the day, the market is always right and one has to always be nimble to take advantage. No complaints.